Radiotherapy SARP PDF
Radiotherapy SARP PDF
Radiotherapy
HISTORY further producing chain reaction. This chain reaction is
controlled by moderators in nuclear reactors, which cannot
X-Ray was discovered by Röntgen in 1885 be done when used as nuclear bombs.
First treatment for malignancy was done in 1896 by using Nuclear fusion: When two low mass nuclei combined
X-rays together to produce one nucleus
Radium was discovered by Marie Curie in 1898 X-Rays are produced when fast moving electron is stopped
First Cobalt-60 therapy Unit was installed in 1951 by a high atomic material anode
First linear accelerator therapy unit was installed in 1970s Electrons are produced by the cathode by thermionic
emission
Electrons have less penetrating property
e
DEFINITION As the energy increases for the photon the penetrating
Nucleus contains Protons (postive charge) and Neutrons Table 1: Units of radiation
(No Charge)
SA
e
For thyroid cancers: Iodine-125 (I-125), Iodine-131 (I-131),
Electromagnetic radiation is a spectrum, which is divided into:
Iodine-123 (I-123)
Nonionizing (visible light, radio waves, cellular signals, etc.)
2/
Ionizing radiation How Photons Interact with Matter? (Tissue
Directly ionizing (Charged Particle—Electrons,
zz
protons)
in Clinical setting)
P,
zz Indirectly ionizing (Neutral Particles—Photons, Coherent scattering, photoelectric effect, compton effect,
Neutrons) pair production)
Photoelectric effect – Utilized in radiodiagnosis (Energy of
R
e
Occurs when there is whole body exposure nonclinically. The
RADIOBIOLOGY 2/ clinical features depends on the dose of radiation
Cerebrovascular syndrome: More than 100 Gy, death
In this DNA is a target in killing cells occurs after 24-48 hours of exposure
Cells which are actively proliferating and poorly Gastrointestinal syndrome: 5 to 12 Gy, death occurs after
P,
differentiated are radiosensitive 10 days
Cells are sensitive at or close to mitosis Hematopoietic syndrome: 2.5 to 5 Gy, death occurs after
Late S Phase: Radioresistant (Because repair occurs in this several weeks to 2 months of exposure.
R
321
RADIATION CARCINOGENESIS Normal tissue reaction to radiation depends on the type of the
structurally defined functional subunit of the organ. Depending
Stochastic Effect: Random, no threshold dose, severity is on this, organs are divided into,
not dose related, damage occurs in germ cell, mutation may Serial organ: Spinal cord
occur Parallel organ: Intestinal Mucosa
Deterministic Effect: Threshold dose present, severity is
dose related. For example 2Gy is the threshold dose for the
lens of eye to develop cataract and for spinal cord 45 Gy is HYPERTHERMIA
the threshold dose for developing injury.
The is a modality used in radiotherapy by utilizing the “heat
Leukemia, thyroid cancer, breast cancer, lung cancer and
shock” range of temperature varies of 41 to 45° is an additive in
bone cancer, skin cancers have radiation-induced etiology.
radiosensitizing as well as synergistic effect for tumor killing.
Cesium-137, Americium – 241, polonium – 210 are used in
Hyperthermic intraperitoneal chemotherapy (HIPEC)
making dirty bombs or for poisoning with radiation.
surgery utilizes this property of thermal killing.
e
ALARA – As low as reasonably achievable.
pruritis, swelling, maculopapular rash, ulceration.
To achieve the radiation protection with reasonable cost Sometimes may involve lung, oral mucosa or GIT.
and sufficient quality, the thickness of material is important:
Concrete wall for the room, lead for the apron and cerrobend
2/ Radiation (Radiotherapy)-Induced Second
alloy for the patient blocking.
Cancers
P,
Objectives of Radiation Protection To name a second malignancy as radiotherapy-induced,
As stated by National Council on Radiation Protection (NCRP) following criteria should be satisfied (Cahan’s Criteria)
Time lag of at least 3 years (sometimes 4 years) after initial
R
To prevent clinically significant radiation-induced
deterministic effects by adhering to dose limits that are treatment
below the apparent or practical threshold The lesion should be within the initial radiation field or in
SA
Occupational
Exposure MALIGNANCIES WHERE
R Cumulative 10 mSv x age 20 mSv/yr 20 mSv/yr RADIOTHERAPY IS USED AS RADICAL
A averaged averaged over
TREATMENT WITH OR WITHOUT
over 5 yrs 5 consecutive
D years CHEMOTHERAPY
I Annual 50 mSv/Yr 50 mSv/yr 30 mSv/yr
Cancer cervix
O for Embryo/ 0.5 mSv/ Total 1 mSv 1 mSv total to Oropharyngeal cancers
L Fetus month to abdominal the fetus Laryngeal cancers
(Effective surface
O dose after
Nasopharyngeal cancers
G pregnancy
Cancer anal canal
Cancer esophagus
Y declared
Oral cavity cancers.
Public- 5 mSv/yr 1 mSv/yr 1 mSv/yr
Effective Dose
322
MALIGNANCIES WHERE PALLIATIVE RADIOTHERAPY
RADIOTHERAPY IS USED AS It is indicated in the following conditions:
ADJUVANT TREATMENT (AFTER Bleeding
SURGERY) Bone pain due to metastasis
To relieve obstruction in esophageal cancer
Breast cancer
Respiratory obstruction due to external malignancy.
Brain tumors
Oral cavity cancers
Gastric cancers CRANIOSPINAL IRRADIATION
Endometrial cancers
Medulloblastoma
Ependymoma
NONMALIGNANT CONDITIONS Intracranial Germinoma
TREATED WITH RADIATION Astrocytoma with subarachnoid seeding.
Meningioma
Craniopharyngioma PROPHYLACTIC CRANIAL
Acoustic schwannoma IRRADIATION
AV malformations
Trigeminal neuralgia Acute lymphoblastic leukemia
Pituitary adenoma. Small cell carcinoma of lung after chemotherapy.
e
STANDARD THERAPEUTIC DOSES 2/ HIGHLY RADIOSENSITIVE TUMORS
Cancer cervix – 85 Gy to point A (Point where ureter crosses Ewings Sarcoma
uterine artery) Seminoma
P,
Head and neck cancers: 66 Gy to 72 Gy Dysgerminoma
Brain tumors – 54 Gy to 60 Gy Nasopharyngeal carcinoma.
Prostate cancer – 80 Gy
R
Melanoma
Osteosarcoma
EMERGENCY RADIOTHERAPY
The radioresistance can be overcome by hypofractionation of
It is indicated in the following conditions: radiation (High dose per fraction as in stereotactic radiosurgery).
Spinal cord compression due to metastasis
Malignant bleeding
Superior venacava syndrome
Brain metastases.
Chapter 5 • Radiotherapy
323